Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II

Archives of Virology

Volumn 160, Issue 5, 2015, Pages 1163-1170

  Takano, Tomomi ^a   Nakano, Kenta ^a   Doki, Tomoyoshi ^a   Hohdatsu, Tsutomu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5-(N,N-HEXAMETHYLENE)AMILORIDE; AMILORIDE; ANTIVIRUS AGENT; VIRUS ENVELOPE PROTEIN;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CAT; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; FELINE CORONAVIRUS; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; SEROTYPE; VIRUS LOAD; VIRUS REPLICATION;

AMILORIDE; ANIMALS; ANTIVIRAL AGENTS; CATS; CORONAVIRUS, FELINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROBIAL SENSITIVITY TESTS; SEROGROUP; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84930883917     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2370-x     Document Type: Article

References (26)

1. Agirre A, Barco A, Carrasco L, Nieva JL (2002) Viroporin-mediated membrane permeabilization. Pore formation by nonstructural poliovirus 2B protein. J Biol Chem 277:40434–40441
2. Bálint Á, Farsang A, Zádori Z, Hornyák Á, Dencso L, Almazán F, Enjuanes L, Belák S (2012) Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies of the role of ORF3abc in viral cell tropism. J Virol 86:6258–6267
3. Bodelón G, Labrada L, Martínez-Costas J, Benavente J (2002) Modification of late membrane permeability in avian reovirus-infected cells: viroporin activity of the S1-encoded nonstructural p10 protein. J Biol Chem 277:17789–17796
4. Griffin SD, Beales LP, Clarke DS, Worsfold O, Evans SD, Jaeger J, Harris MP, Rowlands DJ (2003) The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535:34–38
5. Guinea R, Carrasco L (1994) Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Lett 343:242–246
6. Hohdatsu T, Okada S, Ishizuka Y, Yamada H, Koyama H (1992) The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci 54:557–562
7. Hohdatsu T, Sasamoto T, Okada S, Koyama H (1991) Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683. Vet Microbiol 28:13–24
8. Hyser JM, Collinson-Pautz MR, Utama B, Estes MK (2010) Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. MBio 1(5):e00265-10
9. Ito M, Yanagi Y, Ichinohe T (2012) Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog 8(8):e1002857
10. Kummrow M, Meli ML, Haessig M, Goenczi E, Poland A, Pedersen NC, Hofmann-Lehmann R, Lutz H (2005) Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol 12:1209–1215
11. Lane JW, McBride DW Jr, Hamill OP (1992) Structure-activity relations of amiloride and its analogues in blocking the mechanosensitive channel in Xenopus oocytes. Br J Pharmacol 106:283–286
12. Liao Y, Lescar J, Tam JP, Liu DX (2004) Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability. Biochem Biophys Res Commun 325:374–380
13. Liao Y, Yuan Q, Torres J, Tam JP, Liu DX (2006) Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein. Virology 349:264–275
14. Lin CN, Su BL, Wang CH, Hsieh MW, Chueh TJ, Chueh LL (2009) Genetic diversity and correlation with feline infectious peritonitis of feline coronavirus type I and II: a 5-year study in Taiwan. Vet Microbiol 136:233–239
15. Lu W, Zheng BJ, Xu K, Schwarz W, Du L, Wong CK, Chen J, Duan S, Deubel V, Sun B (2006) Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci USA 103:12540–12545
16. Madan V, García Mde J, Sanz MA, Carrasco L (2005) Viroporin activity of murine hepatitis virus E protein. FEBS Lett 579:3607–3612
17. Melton JV, Ewart GD, Weir RC, Board PG, Lee E, Gage PW (2002) Alphavirus 6K proteins form ion channels. J Biol Chem 277(49):46923–46931
18. Motokawa K, Hohdatsu T, Hashimoto H, Koyama H (1996) Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 40:425–433
19. Nelson MT, Conway MA, Knot HJ, Brayden JE (1997) Chloride channel blockers inhibit myogenic tone in rat cerebral arteries. J Physiol 502:259–264
20. Nieva JL, Madan V, Carrasco L (2012) Viroporins: structure and biological functions. Nat Rev Microbiol 10:563–574
21. Olsen CW (1993) A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet Microbiol 36:1–37
22. Pedersen NC (2009) A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg 11:225–258
23. Shiba N, Maeda K, Kato H, Mochizuki M, Iwata H (2007) Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet Microbiol 124:348–352
24. Takano T, Hohdatsu T, Hashida Y, Kaneko Y, Tanabe M, Koyama H (2007) A “possible” involvement of TNF-alpha in apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis. Vet Microbiol 119:121–131
25. Wilson L, Gage P, Ewart G (2006) Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology 353:294–306
26. Zhang R, Wang K, Lv W, Yu W, Xie S, Xu K, Schwarz W, Xiong S, Sun B (2014) The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production. Biochim Biophys Acta 1838:1088–1095